Last reviewed · How we verify
Sacubitril and Valsartan-Test product
Sacubitril and Valsartan-Test product is a Small molecule drug developed by Humanis Saglık Anonim Sirketi. It is currently in Phase 1 development.
At a glance
| Generic name | Sacubitril and Valsartan-Test product |
|---|---|
| Sponsor | Humanis Saglık Anonim Sirketi |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Dizziness
- Fatigue
- Diarrhoea
- Vomiting
- Hypotension
Key clinical trials
- Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg) (PHASE1)
- A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions (PHASE1)
- A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions (PHASE1)
- Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets (PHASE1)
- Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure
- A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions (PHASE1)
- Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. (PHASE4)
- ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sacubitril and Valsartan-Test product CI brief — competitive landscape report
- Sacubitril and Valsartan-Test product updates RSS · CI watch RSS
- Humanis Saglık Anonim Sirketi portfolio CI
Frequently asked questions about Sacubitril and Valsartan-Test product
What is Sacubitril and Valsartan-Test product?
Sacubitril and Valsartan-Test product is a Small molecule drug developed by Humanis Saglık Anonim Sirketi.
Who makes Sacubitril and Valsartan-Test product?
Sacubitril and Valsartan-Test product is developed by Humanis Saglık Anonim Sirketi (see full Humanis Saglık Anonim Sirketi pipeline at /company/humanis-sagl-k-anonim-sirketi).
What development phase is Sacubitril and Valsartan-Test product in?
Sacubitril and Valsartan-Test product is in Phase 1.
What are the side effects of Sacubitril and Valsartan-Test product?
Common side effects of Sacubitril and Valsartan-Test product include Dizziness, Fatigue, Diarrhoea, Vomiting, Hypotension.